04:43:05 EST Sun 25 Feb 2018
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:BLCM - Bellicum Pharmaceuticals, Inc. - http://www.bellicum.com04:43:05 EST
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BLCM - Q0.85.23 · 7.220.27.03+0.365.41,317.59,3495,3607.25  7.5348  6.7915.55  5.0217:44:5311:0515 min RT 2¢

Recent Trades - Last 10 of 5360
Time ETExPriceChangeVolume
17:44:53Q7.030.3621,351
16:40:06Q7.100.43400
16:23:42Q7.050.386
16:20:45Q7.050.389
16:00:07Q7.030.3671
16:00:06Q7.030.36100
16:00:03Q7.030.36400
16:00:03Q7.030.361,288
16:00:00Q7.030.3623,260
15:59:57Q7.030.3668

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2018-02-24 08:10U:BLCMNews ReleasePomerantz Law Firm Announces the Filing of a Class Action against Bellicum Pharmaceuticals, Inc. and Certain Officers – BLCM
2018-02-23 11:05U:BLCMNews ReleaseBELLICUM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Bellicum Pharmaceuticals, Inc. To Contact The Firm
2018-02-23 07:00U:BLCMNews ReleaseBellicum Announces Update on Clinical Hold of U.S. BPX-501 Studies
2018-02-21 07:00U:BLCMNews ReleaseBellicum Pharmaceuticals Appoints Edmund P. Harrigan, M.D. to its Board of Directors
2018-02-20 17:42U:BLCMNews ReleaseIMPORTANT INVESTOR REMINDER FOR ALL OWNERS OF BELLICUM PHARMACEUTICALS, INC.: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District o
2018-02-20 14:50U:BLCMNews ReleaseINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Bellicum Pharmaceuticals, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit
2018-02-17 08:00U:BLCMNews ReleasePomerantz Law Firm Announces the Filing of a Class Action against Bellicum Pharmaceuticals, Inc. and Certain Officers - BLCM
2018-02-15 16:12U:BLCMNews ReleaseBLCM LOSS NOTICE: Rosen Law Firm Reminds Bellicum Pharmaceuticals, Inc. Investors of Important Deadline in Class Action – BLCM
2018-02-13 18:34U:BLCMNews ReleaseBELLICUM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Bellicum Pharmaceuticals, Inc. To Contact The Firm
2018-02-13 10:10U:BLCMNews ReleaseSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Bellicum Pharmaceuticals, Inc. (BLCM) & Lead Plaintiff Deadline – April 9, 2018
2018-02-12 15:18U:BLCMNews ReleaseFederman & Sherwood Announces Filing of Securities Class Action Lawsuit Against  Bellicum Pharmaceuticals, Inc.
2018-02-09 12:36U:BLCMNews ReleaseRobbins Arroyo LLP: Bellicum Pharmaceuticals, Inc. (BLCM) Misled Shareholders According to a Recently Filed Class Action
2018-02-08 13:31U:BLCMNews ReleaseSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM) To Contact Brower Piven Before The Lead Plaintiff Deadli
2018-02-07 19:00U:BLCMNews ReleaseGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bellicum Pharmaceuticals, Inc. (BLCM)
2018-02-07 10:10U:BLCMNews ReleaseSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Bellicum Pharmaceuticals, Inc. (BLCM) & Lead Plaintiff Deadline - April 9, 2018